Diabetes

Hyperbaric Oxygen Therapy (HBOT) Research for Diabetes.

Hyperbaric Oxygen Therapy for Diabetes

Hyperbaric Oxygen Therapy for Diabetes

Diabetes affects more than 12 million people annually, and the experienced team at Skaggs Chiropractic in Joplin is always seeking the most effective methods to help our patients with diabetes. Hyperbaric oxygen therapy (HBOT) does just that for patients living with...

read more
The clinical use of hyperbaric oxygen in the treatment of Danish patients with diabetic foot ulcers.

The clinical use of hyperbaric oxygen in the treatment of Danish patients with diabetic foot ulcers.

Patients with diabetic foot ulcers (DFU) suffer from diabetes-related complications and comor-bidities. Hyperbaric oxygen therapy (HBOT) is a treatment modality with limited capacity used in the treatment of DFUs. It is important to ensure that HBOT is offered to patients who are suitable for this treatment regarding effect, compliance and life expectancy. The objective of the present study was to describe the population of patients with DFU who were referred to HBOT in Denmark in the 1999-2016 period. All patients with DFU who were treated at the HBOT chamber in Copenhagen during the study period were considered. Patients with an invalid social security number or an incorrect diagnosis were excluded. Data on comor-bidities, amputation and death were extracted from the Danish National patient Registry and the Danish Civil Registration System.

read more
Vitamin C for Type 2 Diabetes Mellitus and Hypertension

Vitamin C for Type 2 Diabetes Mellitus and Hypertension

Abstract It is suggested that supplementation of vitamin C reduces hyperglycemia and lowers blood pressure in hypertensives by enhacing the formation of prostaglandin E1 (PGE1), PGI2 (prostacyclin), endothelial nitric oxide (eNO), and restore essential fatty acid...

read more

Malnutrition screening in outpatients receiving hyperbaric oxygen therapy: an opportunity for improvement?

Outpatients who receive hyperbaric oxygen treatment (HBOT) may represent a group at significant risk of malnutrition owing to the underlying conditions that are often treated with HBOT (e.g., non-healing diabetic wounds and radiation-induced skin injury). In this issue, See and colleagues provide new, preliminary evidence of the prevalence of malnutrition in a small group of HBOT outpatients treated in an Australian hospital, reporting that approximately one-third of patients receiving HBOT were at risk of malnutrition. To our knowledge, routine malnutrition screening is not available in HBOT centres providing outpatient treatment, which may be a key gap in the nutrition care of these patients. Malnutrition screening was developed to identify those at risk of malnutrition across the healthcare continuum.

read more